Treg-specific IL-27Rα deletion uncovers a key role for IL-27 in Treg function to control autoimmunity
Dysregulated Foxp3⁺ Treg functions result in uncontrolled immune activation and autoimmunity. Therefore, identifying cellular factors modulating Treg functions is an area of great importance. Here, using Treg-specific Il27ra −/− mice, we report that IL-27 signaling in Foxp3⁺ Tregs is essential for T...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 114; no. 38; pp. 10190 - 10195 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
19.09.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Dysregulated Foxp3⁺ Treg functions result in uncontrolled immune activation and autoimmunity. Therefore, identifying cellular factors modulating Treg functions is an area of great importance. Here, using Treg-specific Il27ra
−/− mice, we report that IL-27 signaling in Foxp3⁺ Tregs is essential for Tregs to control autoimmune inflammation in the central nervous system (CNS). Following experimental autoimmune encephalomyelitis (EAE) induction, Treg-specific Il27ra
−/− mice develop more severe EAE. Consistent with the severe disease, the numbers of IFNγ- and IL-17–producing CD4 T cells infiltrating the CNS tissues are greater in these mice. Treg accumulation in the inflamed CNS tissues is not affected by the lack of IL-27 signaling in Tregs, suggesting a functional defect of Il27ra
−/− Tregs. IL-10 production by conventional CD4 T cells and their CNS accumulation are rather elevated in Treg-specific Il27ra
−/− mice. Analysis with Treg fate-mapping reporter mice further demonstrates that IL-27 signaling in Tregs may control stability of Foxp3 expression. Finally, systemic administration of recombinant IL-27 in Treg-specific Il27ra
−/− mice fails to ameliorate the disease even in the presence of IL-27–responsive conventional CD4 T cells. These findings uncover a previously unknown role of IL-27 in regulating Treg function to control autoimmune inflammation. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 2Present address: Ulsan National Institute of Science and Technology, Ulsan, Korea. Edited by Vijay K. Kuchroo, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, and accepted by Editorial Board Member Tadatsugu Taniguchi August 2, 2017 (received for review February 22, 2017) Author contributions: J.D., D.K., and B.M. designed research; J.D., D.K., S.K., A.V.-T., N.D., E.J., and V.N. performed research; D.A.A.V. contributed new reagents/analytic tools; J.D., D.K., S.K., A.V.-T., N.D., E.J., V.N., T.D., X.L., A.H.T., S.A.S., W.M.B., and B.M. analyzed data; and B.M. wrote the paper. 1Present address: Cleveland Cord Blood Center, Cleveland, OH 44106. 3Deceased November 18, 2015. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.1703100114 |